Observer
  • Business
  • Art
  • Lifestyle
Newsletters
  • Business
    • Finance
    • Media
    • Technology
    • Policy
    • Wealth
    • Insights
    • Interviews
  • Art
    • Art Fairs
    • Art Market
    • Art Reviews
    • Auctions
    • Galleries
    • Museums
    • Interviews
  • Lifestyle
    • Nightlife & Dining
    • Style
    • Travel
    • Interviews
  • Power Lists
    • Nightlife & Dining
    • Art
    • A.I.
    • PR
  • About
    • About Observer
    • Advertise With Us
    • Reprints
Newsletters

FDA

A robot hand optimizing medical processes

The Economics of Drug Development: What it Will Really Take to Reduce Drug Prices

Orr Inbar, CEO and co-founder of QuantHealth, unpacks the growing frustration over drug prices and the misperceptions fueling distrust in the pharmaceutical industry. With clinical trials now more expensive and less successful than ever, Inbar explores how A.I.-powered simulations can fundamentally change the economics of drug development, reducing development costs, boosting approval rates and ultimately bringing more affordable treatments to market.
By Orr Inbar
Food and Drug Administration Commissioner (FDA) Martin Makary waits for the start of a press conference.

New FDA Chief Martin Makary Says DOGE Cuts Haven’t Hit Science Staff

The new FDA chief reiterated his commitment to speeding up drug approval processes and run the agency by "gold standard science" and "common sense."
By Sissi Cao
Cellphone with 'Neuralink' logo displayed on screen

Elon Musk’s Neuralink Aims to Implant 10 Times More Brain Chips in 2025

Neuralink recently implanted its brain device into a third patient, according to Elon Musk.
By Alexandra Tremayne-Pengelly

CBD Industry: FDA’s Vague Warning Confuses Consumers Even More

By Gabriela Barkho

FDA Warns Companies Over Illegal Sales, Calls CBD ‘Potentially Harmful’

By Gabriela Barkho
breast implants

No FDA, Breast Implants Aren’t That Dangerous

By Ross Marchand

Here’s What Juul’s State Lawsuits Could Mean for Its FDA Approval

By Gabriela Barkho
Never mind that there’s zero evidence that menthol cigarettes are uniquely bad for smokers’ health.

Menthol Prohibition Would Criminalize Communities of Color

By Ross Marchand

New Survey Shows Most Americans Wrongfully Assume CBD Products Are FDA Approved

By Gabriela Barkho
American exceptionalism lives on in the e-cigarette, where profit lust dealt a death blow to a life-saving medical concept, and Americans will likely die because of it.

It May Actually Be Good That E-Cigs Are More Addictive Than Tobacco—But Juul Ruined It

By Chris Roberts

Juul Officially Stops Selling Flavored Pods Until the FDA Approves Them

By Gabriela Barkho

FDA Announces ‘Smarter Food Safety’ Initiative to Address Tech Innovation

By Gabriela Barkho

This Is How Much Impossible Foods Spent on Lobbying to Get Its Fake Meat Into Stores

By Gabriela Barkho
vaping

US Moves to Ban E-Cigs After Rash of Vaping-Related Illnesses and Deaths

By Chris Roberts
Charlotte's Web CEO Deanie Elsner

Charlotte’s Web CEO Predicts Majority of CBD Sales Will Come From Large Retailers

By Gabriela Barkho
CBD oil

Settling the Debate: Is CBD Oil Legal?

By Todd Dunsmore
CBD Tea

How Can You Tell If Your CBD Product Is Good (or Even Has CBD)?

By Chris Roberts

How the CBD Industry Is Reacting to Increased Calls for FDA Regulation

By Gabriela Barkho

Impossible Burger Gets FDA Approval to be Sold at Grocery Stores

By Gabriela Barkho
E-liquids containing CBD are seen in a shop in the Paris area on June 14, 2018.

The Process to Regulate CBD Will Speed Up, According to the FDA

By Todd Dunsmore

A CBD Cure for Cancer, Alzheimer’s and Pet Anxiety? FDA Says It’s Bogus.

By Sissi Cao

5 Tips to Avoid Prime Day Scams, According to an Ex-Amazon Manager

By Sissi Cao
Juul

Nicotine’s Electronic Epidemic Demands Regulation

By Mitchell Gunter

Study: 90 Percent of CBD Businesses Are Operating in FDA ‘Gray Area’

By Sissi Cao
More
  • ART
  • BUSINESS
  • LIFESTYLE
  • POWER LISTS
  • INTERVIEWS
  • ABOUT
  • ADVERTISE
  • CONTACT
  • NEWSLETTERS
  • RSS FEEDS
  • SITEMAP
  • TERMS
  • PRIVACY
  • REPRINTS
  • Privacy
  • Terms
  • Cookie Settings
  • Do not sell my data
Powered by WordPress VIP

We noticed you're using an ad blocker.

We get it: you like to have control of your own internet experience.
But advertising revenue helps support our journalism.

To read our full stories, please turn off your ad blocker.
We'd really appreciate it.

How Do I Whitelist Observer?

How Do I Whitelist Observer?

Below are steps you can take in order to whitelist Observer.com on your browser:

For Adblock:

Click the AdBlock button on your browser and select Don't run on pages on this domain.

For Adblock Plus on Google Chrome:

Click the AdBlock Plus button on your browser and select Enabled on this site.

For Adblock Plus on Firefox:

Click the AdBlock Plus button on your browser and select Disable on Observer.com.

Then Reload the Page